We report on a 45-year-old 
Introduction
Intimal sarcoma of the pulmonary artery is rare (1) . This tumor was first described at autopsy by Mandelstamm in 1923 (2) . It is easily misdiagnosed as a chronic pulmonary embolism, mediastinal mass, or tumor emboli, leading to inappropriate treatment, such as prolonged anticoagulation or thrombolysis. The prognosis of pulmonary artery sarcoma is extremely poor, with a median survival time without surgical resection of only 1.5 (4) . Chemotherapy and radiotherapy for pulmonary artery sarcoma remains controversial, although some studies have demonstrated their effectiveness (5, 6) . We report on a 45-year-old woman with intimal sarcoma of the pulmonary artery that treatment with surgery, radiotherapy, and chemotherapy successfully lengthened survival.
months (3). Surgical resection decreases clinical symptoms and lengthens survival

Case Report
A 45-year-old woman presented with a chief complaint of shortness of breath, which had gradually worsened over the preceding 2 months. She had no significant past medical history. She had never smoked but sometimes drank alcohol. Physical examination revealed tachypnea (20 i g u r e 1 . A: A c h e s t X-r a y f i l m s h o we d e n l a r g e me n t o f t h e l e f t ma i n p u l mo n a r y a r t e r y . 1 B : CE -CT o f t h e c h e s t s h o we d a n i n t r a l u mi n a l h y p o a t t e n u a t e d a r e a f r o m t h e ma i n p u l mo n a r y a r t e r y i n t o t h e r i g h t ma i n p u l mo n a r y a r t e r y a n d b i l a t e r a l l o b a r p u l mo n a r y a r t e r i e s . (Fig. 1A) . Fig. 2A) . Specimens of the tumor were immunohistochemically positive for vimentin and were focally positive for alpha-smooth muscle actin and CD34 but were negative for desmin, cytokeratin, S-100 protein, and CD31 (Figs. 2B, 2C ). On the basis of morphological and immunohistochemical findings, the tumor was diagnosed as an intimal sarcoma of the pulmonary artery.
Contrast-enhanced computed tomography (CE-CT) of the chest showed an intraluminal hypoattenuated area extending from the main pulmonary artery into the right main pulmonary artery and the bilateral lobar pulmonary arteries, consolidation in the upper lobe of the right lung, and ground-glass opacity (GGO) in the lower lobes of the both lungs, most likely representing infarction (Fig. 1B). Abdominal and pelvic CE-CT showed no evidence of metastatic disease. A tumor of the pulmonary artery was diagnosed. The patient underwent resection of a tumor of the pulmonary artery. Resection was performed with cardiopulmonary bypass. The opening of the main pulmonary artery and right pulmonary artery revealed a 3×3×2-cm lobulated mass that had attached to the intima of the main pulmonary artery and had extended through the lumens of both the right and left pulmonary arteries. The tumor was entirely removed without injury to the interventricular septum. The pulmonary artery was reconstructed with a pericardial patch. The resected tumor included mucoid regions. The cytology of pericardial effusion was class II. Histological examination of the tumor revealed proliferation of spindle cells with pleomorphic nuclei in a myxoid and collagenized background (
CE-CT of the chest immediately after surgery did not show an obvious intraluminal hypoattenuated area in the pulmonary artery. However, 2 months after surgery, chest CE-CT showed an intraluminal hypoattenuated area along
F i g u r e 3 . A, B : T wo mo n t h s a f t e r s u r g e r y , c h e s t CE -CT s h o we d a n i n t r a l u mi n a l h y p o a t t e n u a t e d a r e a a l o n g t h e ma i n p u l mo n a r y a r t e r y a n d b i l a t e r a l l o b a r p u l mo n a r y a r t e r i e s , c o n s o l i d a t i o n i n t h e u p p e r l o b e o f t h e r i g h t l u n g , a n d GGO i n t h e l o we r l o b e o f b o t h l u n g s . C, D: Af t e r r a d i o t h e r a p y c h e s t CE -CT s h o we d s h r i n k a g e o f a n i n t r a l u mi n a l h y p o a t t e n u a t e d a r e a a l o n g t h e r i g h t ma i n p u lmo n a r y a r t e r y a n d b i l a t e r a l p u l mo n a r y l o b a r a r t e r i e s a n d r e g r e s s i o n o f c o n s o l i d a t i o n a n d GGO.
the main pulmonary artery and bilateral lobar pulmonary arteries, consolidation in the upper lobe of the right lung, and GGO in the lower lobe of the both lungs (Figs. 3A, 3B (Figs. 3C, 3D) (10) . Therefore, the diagnosis as a pulmonary artery sarcoma seems to be the most appropriate basis for selecting treatment.
Although the patient had received 2 courses of chemotherapy with carboplatin (with a target area under the concentration versus time curve of 4 mg min/mL using the Calvert formula on day 1) and amrubicin (30 mg/m 2 on days 1, 2, and 3) every 3 weeks, the tumor had enlarged slightly. After chemotherapy, the patient received radiotherapy that consisted of 53 Gy in initially 3 fractions of 3-Gy per fraction and 22 fractions of 2-Gy per fractions centered around the tumor. The tumor along the right main pulmonary artery and bilateral pulmonary lobar arteries shrank 60% in length compared with before radiotherapy, and CE-CT showed decreased consolidation and GGO
The roles of chemotherapy and radiotherapy in the treatment of pulmonary artery sarcoma remain undefined. However, some reports have shown that chemotherapy or radiotherapy is effective against pulmonary artery sarcoma (5, 6, 11) . The addition to surgical treatment of chemotherapy or radiotherapy or both has lengthened survival times compared with surgery alone (12, 13 (19) . In addition, ifosfamide is beneficial for patients in whom treatment with doxorubicin-based regimens has failed (20) . Therefore, we recommended chemotherapy with ifosfamide as second-line chemotherapy to the patient and her husband. However, they refused second-line chemotherapy.
In conclusion, radiotherapy and chemotherapy should be attempted in patients with pulmonary artery sarcoma that is unresectable or is recurrent after surgery, although the most effective way of prolonging survival has been surgical intervention. The survival of patients with pulmonary artery sarcoma can be prolonged if the tumors are diagnosed early and if multimodality treatment, including radical surgical resection and chemotherapy and radiotherapy, is performed.
